Co-Diagnostics, Inc. — Director's Dealing 2021

Jan 22, 2021

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Co-Diagnostics, Inc. (CODX)
CIK: 0001692415
Period of Report: 2017-09-19

Reporting Person: Reagents, LLC (Former 10% Owner)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2020-04-01	Common Stock	J	25000	$192505	Disposed	1746796	Direct
2017-09-19	Common Stock	J	181817	—	Disposed	1771796	Direct

Footnotes

F1: Pursuant to a stock pledge agreement between the Reporting Person and an unaffiliated third party (the "Pledgee"), dated on or about July, 2018, as amended (the "Pledge Agreement"), the Reporting Person secured a promissory note by a pledge of 25,000 shares of common stock of the Issuer (the "Shares"). On January 28, 2020, the Reporting Person ceased to be a 10% owner of shares of common stock of the Issuer. Thereafter, in April of 2020, the Pledgee exercised its right under the Pledge Agreement and transferred the entirety of the Shares as full and final satisfaction of the $192,505 outstanding principal amount due under the promissory note. Accordingly, although this Form 4 is being filed to report such transfer from the Reporting Person, the transfer occurred after the Reporting Person ceased to be a 10% owner of shares of common stock of the Issuer.

F2: The total number of shares reported contains a de minimis correction to the balance on the Reporting Person's Form 3 previously filed on September 19, 2017.